Physician
Martin's Point Health Care, INC.
Martin's Point Health Care, INC. was paid $5.94M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 78% of everything it billed.
33Billing provider infoMARTIN'S POINT HEALTH CARE, INC.
PORTLAND, ME 04104
PORTLAND, ME 04104
33aNPI1366474611assigned 07/07/2006
33bProvider typeNeuromusculoskeletal Medicine & OMM Physician
28Total paid$5.94M
24GClaims126,008
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Neuromusculoskeletal Medicine & OMM Physician providers in Maine
Rank by total paid#1 of 14
Median peer was paid$61K
This provider vs. median98×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,495 | $685K | |
| 2019 | 16,183 | $709K | |
| 2020 | 13,283 | $549K | |
| 2021 | 25,123 | $939K | |
| 2022 | 19,786 | $1.03M | |
| 2023 | 19,942 | $1.12M | |
| 2024incomplete | 16,196 | $908K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 78% | 67,466 | 62,580 | $4.60M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 17,570 | 16,341 | $888K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 4,608 | 4,470 | $75K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.1% | 1,958 | 1,688 | $63K |
| 0011A | <1% | 1,535 | 1,521 | $34K | |
| 0012A | <1% | 1,513 | 1,499 | $33K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,934 | 13,658 | $21K |
| 90686 | <1% | 2,502 | 2,415 | $20K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,947 | 2,770 | $19K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 627 | 612 | $17K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 408 | 404 | $16K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 188 | 181 | $16K |
55 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 224 | $15K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 122 | $13K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 938 | $13K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 157 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,690 | $8K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 84 | $6K |
| 80305 | <1% | 887 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 69 | $6K |
| 80061 | Lipid panel | <1% | 540 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 403 | $4K |
| 99442 | <1% | 198 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 407 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 50 | $4K |
| 90682 | <1% | 37 | $3K | |
| 0001A | <1% | 88 | $3K | |
| 0240U | <1% | 32 | $3K | |
| 0002A | <1% | 72 | $3K | |
| 0064A | <1% | 78 | $2K | |
| 98927 | <1% | 67 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 78 | $2K |
| 99334 | <1% | 51 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 15 | $1K |
| 92551 | <1% | 120 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 55 | $1K |
| 96127 | <1% | 208 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 38 | $958.32 |
| 90673 | <1% | 13 | $907.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 129 | $849.43 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 66 | $737.14 |
| 0031A | <1% | 44 | $723.64 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 14 | $664.44 |
| 93000 | <1% | 90 | $612.63 | |
| 90480 | <1% | 14 | $547.54 | |
| 99177 | <1% | 55 | $537.68 | |
| 92552 | <1% | 28 | $360.92 | |
| 90461 | <1% | 13 | $325.92 | |
| 99441 | <1% | 39 | $309.03 | |
| D1206 | Topical application of fluoride varnish | <1% | 12 | $294.72 |
| 99173 | <1% | 59 | $249.57 | |
| 83655 | <1% | 13 | $148.44 | |
| 94760 | <1% | 73 | $148.40 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $128.81 |
| 96160 | <1% | 40 | $76.81 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15 | $50.25 |
| 85018 | <1% | 15 | $31.46 | |
| 91301 | 0% | 1,888 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 30 | $0.00 |
| 91307 | 0% | 43 | $0.00 | |
| 90656 | 0% | 87 | $0.00 | |
| 91306 | 0% | 43 | $0.00 | |
| 90698 | 0% | 12 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 13 | $0.00 |
| 91308 | 0% | 12 | $0.00 | |
| 90671 | 0% | 14 | $0.00 | |
| 91300 | 0% | 158 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCORMACK, DAN (CHIEF OPERATING OFFICER)